These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28552464)

  • 21. Top 10 Facts You Need to Know about Pneumococcal Vaccination in Adults.
    Rehman T; Khan ZS
    J Miss State Med Assoc; 2016 Feb; 57(2):32-4. PubMed ID: 27141764
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevalence of influenza vaccination and pneumococcal vaccination in elderly and high-risk patients seen in a university general medicine clinic.
    Lai H; Aronow WS; Gutwein AH
    Am J Ther; 2008; 15(6):528-30. PubMed ID: 19127136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indicators of influenza and pneumococcal vaccination in French nursing home residents in 2011.
    de Souto Barreto P; Lapeyre-Mestre M; Vellas B; Rolland Y
    Vaccine; 2014 Feb; 32(7):846-51. PubMed ID: 24370710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Navigating pneumococcal vaccination in adults.
    Pallotta A; Rehm SJ
    Cleve Clin J Med; 2016 Jun; 83(6):427-33. PubMed ID: 27281256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumococcal Vaccination in Different Specialties.
    Sureshkumar D
    J Assoc Physicians India; 2015 Apr; 63(4 Suppl):29-30. PubMed ID: 26562961
    [No Abstract]   [Full Text] [Related]  

  • 26. Pneumococcal seroepidemiology in Turkey: implications for vaccine coverage.
    Erdem H; Sener B
    Vaccine; 2008 Mar; 26(10):1271-3. PubMed ID: 18272259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pneumococcal vaccination in France among adults].
    Dubois G
    Bull Acad Natl Med; 2002; 186(8):1461-76; discussion 1476-7. PubMed ID: 12669362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.
    Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Hjuler T; Kaltoft M; Krogfelt KA; Lambertsen L; Konradsen HB
    Vaccine; 2008 Jul; 26(29-30):3765-71. PubMed ID: 18513840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.
    Fedson DS; Nicolas-Spony L; Klemets P; van der Linden M; Marques A; Salleras L; Samson SI
    Expert Rev Vaccines; 2011 Aug; 10(8):1143-67. PubMed ID: 21810065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patients.
    Nagel J; Geborek P; Saxne T; Jönsson G; Englund M; Petersson IF; Nilsson JÅ; Kapetanovic MC
    Scand J Rheumatol; 2015; 44(4):271-9. PubMed ID: 25656734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predictive of increased influenza and pneumococcal vaccination coverage in long-term care facilities: the CMS-CDC standing orders program Project.
    Bardenheier BH; Shefer A; McKibben L; Roberts H; Rhew D; Bratzler D
    J Am Med Dir Assoc; 2005; 6(5):291-9. PubMed ID: 16165069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report.
    Pasiarski M; Rolinski J; Grywalska E; Stelmach-Goldys A; Korona-Glowniak I; Gozdz S; Hus I; Malm A
    PLoS One; 2014; 9(12):e114966. PubMed ID: 25506837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pneumococcal vaccination of adults: polysaccharide or conjugate.
    Med Lett Drugs Ther; 2009 Jun; 51(1314):47-8. PubMed ID: 19528887
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age].
    Albrecht P; Antczak A; Hryniewicz W; Skoczyńska A; Radzikowski A; Kedziora-Kornatowska K; Bernatowska E; Stompór T; Grodzicki T; Gyrczuk E; Imiela J; Jedrzejczak W; Windak A
    Pol Merkur Lekarski; 2014 Feb; 36(212):79-87. PubMed ID: 24720101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK.
    Jiang Y; Gauthier A; Keeping S; Carroll S
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):913-27. PubMed ID: 25189087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coverage of and factors associated with pneumococcal vaccination in chronic obstructive pulmonary disease.
    Carreño-Ibáñez LV; Esteban-Vasallo MD; Domínguez-Berjón MF; Astray-Mochales J; González Del Yerro C; Iniesta-Fornies D; Gascón-Sancho MJ; Jiménez-García R
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):735-41. PubMed ID: 25946369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreasing invasive pneumococcal disease in the elderly: a state-level analysis.
    McBean AM; Jung K; Hebert PL
    Vaccine; 2006 Jul; 24(27-28):5609-14. PubMed ID: 16725240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Declining invasive pneumococcal disease in the U.S. elderly.
    McBean AM; Park YT; Caldwell D; Yu X
    Vaccine; 2005 Dec; 23(48-49):5641-5. PubMed ID: 16111788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pneumococcal vaccination in splenectomised cancer patients.
    Omlin AG; Mühlemann K; Fey MF; Pabst T
    Eur J Cancer; 2005 Aug; 41(12):1731-4. PubMed ID: 16026979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.